ANTITUMOR-ACTIVITY OF FLAVONE ACETIC-ACID (NSC-347512) IN MICE - INFLUENCE OF IMMUNE STATUS

被引:58
作者
BIBBY, MC [1 ]
PHILLIPS, RM [1 ]
DOUBLE, JA [1 ]
PRATESI, G [1 ]
机构
[1] IST NAZL STUDIO & CURA TUMORI,I-20133 MILAN,ITALY
关键词
D O I
10.1038/bjc.1991.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Flavone acetic acid (FAA) is a synthetic flavonoid with dramatic pre-clinical anti-tumour activity involving a vascular component in its mechanism but no clinical effects have been seen to date. As FAA also had immunomodulatory activity, immunological factors might explain differences in activity between mouse and man. This study examines the influence of host immune status on the anti-tumour activity of FAA. Two human colon tumour xenografts (COBA, HT-29) fail to respond to FAA in nude mice. The lack of activity of FAA against HT-20 xenografts cannot be explained on the basis of limited drug bioavailability as achievable plasma, and tumour levels of FAA are similar to those seen in sensitive murine colon tumours. The immune status of the host also influences the activity of FAA against two transplantable tumours of the mouse colon. Both these tumours are highly responsive to FAA in their normal NMRI hosts, but neither tumours exhibited significant growth delay in thymectomised NMRI or nude hosts. Histological examination of treated tumours revealed significant areas of haemorrhagic necrosis in all three hosts. These data suggest a clear immunological component in the mechanism of action of FAA which is separate from the previously described haemorrhagic necrosis.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 32 条
[1]   COMPARISON OF THE EFFECTS OF FLAVONE ACETIC-ACID, FOSTRIECIN, HOMOHARRINGTONINE AND TUMOR NECROSIS FACTOR-ALPHA ON COLON-38 TUMORS IN MICE [J].
BAGULEY, BC ;
CALVELEY, SB ;
CROWE, KK ;
FRAY, LM ;
OROURKE, SA ;
SMITH, GP .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :263-269
[2]  
Bibby M C, 1988, Prog Clin Biol Res, V280, P243
[3]  
BIBBY MC, 1989, CANCER CHEMOTH PHARM, V24, P87
[4]  
BIBBY MC, 1987, J NATL CANCER I, V78, P539
[5]   REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J].
BIBBY, MC ;
DOUBLE, JA ;
LOADMAN, PM ;
DUKE, CV .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) :216-222
[6]   FACTORS INVOLVED IN THE ANTICANCER ACTIVITY OF THE INVESTIGATIONAL AGENTS LM985 (FLAVONE ACETIC-ACID ESTER) AND LM975 (FLAVONE ACETIC-ACID) [J].
BIBBY, MC ;
DOUBLE, JA ;
PHILLIPS, RM ;
LOADMAN, PM .
BRITISH JOURNAL OF CANCER, 1987, 55 (02) :159-163
[7]   UNIQUE CHEMOSENSITIVITY OF MAC-16 TUMORS TO FLAVONE ACETIC-ACID (LM975, NSC-347512) [J].
BIBBY, MC ;
DOUBLE, JA ;
LOADMAN, PM .
BRITISH JOURNAL OF CANCER, 1988, 58 (03) :341-344
[8]   ANTIPROLIFERATIVE PROPERTIES OF FLAVONE ACETIC-ACID (NSC-347512) (LM-975), A NEW ANTICANCER AGENT [J].
CAPOLONGO, LS ;
BALCONI, G ;
UBEZIO, P ;
GIAVAZZI, R ;
TARABOLETTI, G ;
REGONESI, A ;
YODER, OC ;
DINCALCI, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (10) :1529-1535
[9]   FLAVONE ACETIC-ACID (LM-975-NSC-347512) ACTIVATION TO CYTO-TOXIC SPECIES INVIVO AND INVITRO [J].
CHABOT, GG ;
BISSERY, MC ;
GOUYETTE, A .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (05) :273-276
[10]  
CHING CM, 1988, EUR J CANCER CLIN ON, V24, P1521